Biohaven Ltd. (BHVN) — Stock Score Summary

Biohaven Ltd. (BHVN) has a MoatMap StockRank of 14/100 based on Quality (21/100), Value (31/100), and Momentum (46/100) factor scores. The current signal is STRONG SELL. Biohaven is a clinical-stage biopharmaceutical company with high cash burn. It lacks the structural profitability, high ROIC, and pricing power of a quality compounder, and is highly dependent on binary clinical trial readouts.

Biohaven Ltd. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for rare diseases, with a particular focus on central nervous system (CNS) disorders. Formed from the spin-off of certain assets after Pfizer's acquisition of its predecessor, the company retains a pipeline of early to mid-stage candidates. BHVN aims to address significant unmet medical needs in niche neuropsychiatric and neurodegenerative conditions by leveraging established scientific expertise.

Key Financial Metrics

Price$11.09
Market Cap$1.5B
P/E (Forward)-5.84
Price/Book13.26
Return on Equity-333.0%
Return on Invested Capital-222.2%
Debt/Equity220.99
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-379M

Biohaven Ltd. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Biohaven Ltd.’s (BHVN) StockRank?
MoatMap’s StockRank for Biohaven Ltd. (BHVN) is 14/100, with a Strong Sell signal. It is a composite of Quality (21), Value (31), and Momentum (46) factor ranks across MoatMap’s 19,000+ stock universe.
Does Biohaven Ltd. have an economic moat?
Biohaven Ltd. (BHVN) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Biohaven Ltd. a buy, hold, or sell?
MoatMap’s current signal for Biohaven Ltd. (BHVN) is Strong Sell, based on a StockRank of 14/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Biohaven Ltd. in?
Biohaven Ltd. (BHVN) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksBHVN deep dive reportAI ChampionsHow we score stocksSense-check another stock